
Yakin Medic targets global expansion with Singapore IPO
KUALA LUMPUR: Yakin Medic Sdn Bhd, a leading Malaysian provider of active live stem cell therapies, is set to expand into new markets as part of its growth strategy. To support this, the company plans to launch an initial public offering (IPO) on the Singapore Exchange (SGX) Catalist Board in